Eric Mosbrooker's most recent trade in Avidity Biosciences Inc was a trade of 6,563 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Sept. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avidity Biosciences Inc | Eric Mosbrooker | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2025 | 6,563 | 183,750 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Eric Mosbrooker | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 47.07 per share. | 03 Sep 2025 | 6,563 | 55,000 | - | 47.1 | 308,936 | Common Stock |
| Avidity Biosciences Inc | Eric Mosbrooker | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.05 per share. | 03 Sep 2025 | 6,563 | 61,563 | - | 9.0 | 59,395 | Common Stock |
| Avidity Biosciences Inc | Eric Mosbrooker | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2025 | 124,687 | 190,313 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Eric Mosbrooker | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 44.06 per share. | 06 Aug 2025 | 124,687 | 61,120 | - | 44.1 | 5,494,033 | Common Stock |
| Avidity Biosciences Inc | Eric Mosbrooker | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.05 per share. | 06 Aug 2025 | 124,687 | 185,807 | - | 9.0 | 1,128,417 | Common Stock |
| Avidity Biosciences Inc | Eric Mosbrooker | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 44.06 per share. | 06 Aug 2025 | 6,120 | 55,000 | - | 44.1 | 269,663 | Common Stock |
| Avidity Biosciences Inc | Eric Mosbrooker | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Eric Mosbrooker | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 25,000 | 61,120 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | Eric Mosbrooker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) |